William Thomas Creasman
#114,721
Most Influential Person Now
William Thomas Creasman's AcademicInfluence.com Rankings
William Thomas Creasmanphilosophy Degrees
Philosophy
#4939
World Rank
#7623
Historical Rank
Logic
#2297
World Rank
#3261
Historical Rank
William Thomas Creasmanbiology Degrees
Biology
#6579
World Rank
#9329
Historical Rank
Pathology
#78
World Rank
#165
Historical Rank
Download Badge
Philosophy Biology
William Thomas Creasman's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Pathology University of California, San Francisco
Why Is William Thomas Creasman Influential?
(Suggest an Edit or Addition)William Thomas Creasman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study (1987) (1810)
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study (1991) (931)
- Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. (1990) (849)
- Surgical Pathologic Spread Patterns of Endometrial Cancer (2006) (703)
- The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. (1994) (687)
- Clinical Gynecologic Oncology (1981) (633)
- Surgical Staging in Endometrial Cancer: Clinical—Pathologic Findings of a Prospective Study (1984) (611)
- Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group study (1993) (597)
- Ovarian cancer: screening, treatment, and followup. (1995) (579)
- Revised FIGO staging for carcinoma of the endometrium (2009) (564)
- Interim Guidelines for Management of Abnormal Cervical Cytology (1994) (556)
- New gynecologic cancer staging. (1990) (407)
- Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. (1986) (384)
- Effects of long-term estrogen replacement therapy. I. Metabolic effects. (1979) (354)
- Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. (1986) (352)
- A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. (1989) (349)
- Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240) (2017) (329)
- A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas (1983) (320)
- An alternate approach to early cancer of the vulva. (1979) (304)
- Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. (1980) (298)
- Risk factors and recurrent patterns in Stage I endometrial cancer. (1985) (280)
- A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study (1986) (277)
- Early Stage I Carcinoma of the Vulva Treated With Ipsilateral Superficial Inguinal Lymphadenectomy and Modified Radical Hemivulvectomy: A Prospective Study of the Gynecologic Oncology Group (1992) (261)
- Estrogen Replacement Therapy (1981) (235)
- Hydatidiform Mole. Diagnosis, Management, and Long‐Term Followup of 347 Patients (1975) (232)
- FIGO staging of gynecologic cancer (1999) (228)
- Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. (2004) (226)
- Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A gynecologic oncology group study of second‐line therapy in 105 patients (1991) (225)
- The national cancer data base report on cancer of the vagina (1998) (225)
- Treatment of metastatic trophoblastic disease: good and poor prognosis. (1973) (217)
- Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). (1984) (214)
- Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study. (1995) (205)
- Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experience (2010) (201)
- Effects of long-term estrogen replacement therapy: II. Neoplasia (1979) (189)
- Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin Versus doxorubicin and cyclophosphamide (a phase III trial of the gynecologic oncology group) (1985) (185)
- Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. (2013) (170)
- History of the FIGO cancer staging system (2008) (164)
- Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma. (1985) (164)
- Prognostic significance of hormone receptors in endometrial cancer (1993) (163)
- Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study. (1990) (159)
- Tamoxifen in platinum-refractory ovarian cancer: a Gynecologic Oncology Group Ancillary Report. (1996) (158)
- Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. (2007) (156)
- Adenocarcinoma of the endometrium: its metastatic lymph node potential. A preliminary report. (1976) (155)
- Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. (1981) (151)
- The prognostic value of peritoneal cytology in gynecologic malignant disease. (1971) (150)
- Clinical Correlates of Estrogen‐ and Progesterone‐Binding Proteins in Human Endometrial Adenocarcinoma (1980) (145)
- Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A gynecologic oncology group study (a final report) (1985) (140)
- FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. (1999) (138)
- Prevention of Postoperative Venous Thromboembolism by External Pneumatic Calf Compression in Patients With Gynecologic Malignancy (1984) (133)
- A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. (1989) (129)
- Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin. (1983) (126)
- The role of adjuvant therapy in Stage I ovarian cancer. (1980) (125)
- Phase II trial of clsplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A gynecologic oncology group study (1989) (123)
- Operative management of early invasive epidermoid carcinoma of the vulva. (1975) (121)
- Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? (2004) (120)
- Estrogen and cancer. (2002) (119)
- Ovarian metastases in stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. (1992) (119)
- A Controlled Trial of Two Low-Dose Heparin Regimens for the Prevention of Postoperative Deep Vein Thrombosis (1990) (112)
- Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma. (1979) (105)
- Management of stage IA carcinoma of the cervix. (1985) (99)
- Pelvic exenteration: factors associated with major surgical morbidity. (1989) (99)
- Diethylstilbestrol-induced upper genital tract abnormalities. (1979) (90)
- Epithelial Ovarian Tumors of Low Malignant Potential (1991) (88)
- Surgical management of intestinal obstruction in ovarian cancer. I. Clinical features, postoperative complications, and survival. (1987) (87)
- ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid? (2010) (87)
- Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study. (1998) (86)
- Thromboembolism Complicating Surgery for Cervical and Uterine Malignancy: Incidence, Risk Factors, and Prophylaxis (1983) (86)
- Stage I Borderline Ovarian Tumors (1982) (85)
- Estrogen replacement therapy: is previously treated cancer a contraindication? (1991) (84)
- Evaluation of recombinant human interleukin-12 in patients with recurrent or refractory ovarian cancer: a gynecologic oncology group study. (2001) (83)
- The natural history of postoperative venous thromboemboli in gynecologic oncology: a prospective study of 382 patients. (1984) (82)
- Preoperative Serum Tumor-Associated Antigen Levels in Women With Pelvic Masses (1990) (78)
- Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study. (1995) (75)
- Conservative surgical management of superficially invasive stage I vulvar carcinoma. (1989) (74)
- Hormone replacement therapy In breast cancer (1993) (74)
- Germ Cell Malignancies of the Ovary (1979) (71)
- Significance of true surgical pathologic staging: a Gynecologic Oncology Group Study. (1999) (68)
- Perioperative external pneumatic calf compression as thromboembolism prophylaxis in gynecologic oncology: report of a randomized controlled trial. (1984) (66)
- An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer. (2018) (66)
- Fetal complications of amniocentesis. (1968) (65)
- Carcinoma In Situ of the Cervix An Analysis of 861 Patients (1972) (64)
- The national cancer data base report on early stage invasive vulvar carcinoma (1997) (64)
- Efficacy of Cryosurgical Treatment of Severe Cervical Intraepithelial Neoplasia (1973) (61)
- Risk of exogenous estrogen therapy and endometrial cancer. (1980) (58)
- Effects of long-term estrogen replacement therapy: 1. Metabolic effects. (1979) (58)
- Ovarian carcinoma: histologic and clinical correlation of cytoplasmic estrogen and progesterone binding. (1981) (58)
- Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies. (2003) (57)
- A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study. (1988) (57)
- Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-B (2005) (53)
- Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study. (1997) (51)
- Effects of long-term estrogen replacement therapy: 2. Neoplasia. (1979) (50)
- Endometrial cancer: incidence, prognostic factors, diagnosis, and treatment. (1997) (50)
- Cryosurgery in the Management of Cervical Intraepithelial Neoplasia (1984) (50)
- Transcriptional Suppression, DNA Methylation, and Histone Deacetylation of the Regulator of G-Protein Signaling 10 (RGS10) Gene in Ovarian Cancer Cells (2013) (50)
- Anticoagulation therapy for venous thromboembolism in patients with gynecologic malignancy. (1983) (49)
- Computed tomography in evaluation of patients with ovarian carcinoma in complete clinical remission. Correlation with surgical-pathologic findings. (1986) (48)
- Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study. (1979) (47)
- Computed Tomography in Evaluation of Extrapelvic Lymphadenopathy in Carcinoma of the Cervix (1985) (47)
- Prognostic value of cytologic examination of peritoneal washings in patients with endometrial carcinoma. (1981) (46)
- Screening in ovarian cancer. (1991) (45)
- Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma. (1985) (45)
- Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol. (2017) (45)
- Long-term effects on bladder function following radical hysterectomy with and without postoperative radiation. (1987) (44)
- Coordinate elevation of serum markers in ovarian cancer but not in benign disease (1991) (43)
- Paget's disease of the vulva. (1975) (42)
- A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study. (1996) (41)
- Effects of long-term estrogen replacement therapy. II. Neoplasia. (1979) (40)
- Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence (2017) (39)
- WHI: Now that the dust has settled: a commentary. (2003) (37)
- Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas. (1984) (36)
- Vaginal cancers (2005) (36)
- Antenatal analysis of the human chromosomes. (1966) (36)
- Human lymphoblastoid interferon in the treatment of advanced epithelial ovarian malignancies: a Gynecologic Oncology Group Study. (1985) (36)
- Leiomyosarcoma of the uterus: clinicopathologic study of 21 cases. (1985) (36)
- Assessment of the contemporary management of germ cell malignancies of the ovary. (1985) (36)
- Replacement therapy for breast cancer survivors. A pilot study (1995) (36)
- Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study. (1984) (35)
- Intestinal obstruction in patients with ovarian cancer. Variables associated with surgical complications and survival. (1988) (35)
- Endometrial sarcoma: lymphatic spread pattern. (1978) (35)
- Radioactive chromic phosphate suspension: studies on distribution, dose absorption, and effective therapeutic radiation in phantoms, dogs, and patients. (1980) (34)
- Radical hysterectomy as therapy for early carcinoma of the cervix (1986) (34)
- Phase II trial of cisplatin in advanced or recurrent cancer of the vagina: a Gynecologic Oncology Group Study. (1986) (34)
- Adenocarcinoma of the uterine corpus (1993) (34)
- Complications of Low-Dose Heparin Prophylaxis in Gynecologic Oncology Surgery (1984) (34)
- Retroperitoneal metastatic spread of ovarian cancer. (1978) (33)
- A survey of hospital management practices for vulvar melanoma. (1999) (33)
- Endometrial adenocarcinoma estrogen receptor content: association of clinicopathologic features with immunohistochemical analysis compared with standard biochemical methods. (1987) (33)
- Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer. (2003) (32)
- Role of the fallopian tube in dissemination of malignant cells in corpus cancer (1972) (30)
- Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial. (2015) (30)
- Screening techniques in endometrial cancer (1976) (30)
- Cancer and Pregnancy (2001) (30)
- Endometrial Cancer: Histologic Correlates of Immunohistochemical Localization of Progesterone Receptor and Estrogen Receptor (1989) (29)
- The significance of peritoneal cytology in patients with carcinoma of the cervix. (1984) (29)
- Prognostic value of peritoneal washings in patients with malignant mixed müllerian tumors of the uterus. (1986) (29)
- Immune complexes in ovarian cancer. (1980) (29)
- Microinvasive carcinoma of the cervix. (1973) (29)
- Revision in classification by International Federation of Gynecology and Obstetrics. (1992) (28)
- Intraperitoneal chromic phosphate P 32 as salvage therapy for persistent carcinoma of the ovary after surgical restaging. (1987) (28)
- A Trial of Prophylactic Cefamandole in Extended Gynecologic Surgery (1982) (25)
- Coordinate elevation of serum markers in ovarian cancer but not in benign disease. (1991) (25)
- Percutaneous nephrostomy in gynecologic oncology patients. (1988) (25)
- THE PROGNOSTIC VALUE OF PERITONEAL CYTOLOGY IN GYNECOLOGIC MALIGNANT DISEASE (1972) (25)
- Carcinoma of the Ovary Associated with Pregnancy (1971) (24)
- A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: a Gynecologic Oncology Group study. (1990) (24)
- Meningeal carcinomatosis secondary to advanced squamous cell carcinoma of the cervix: a case report. Meningeal metastasis of advenced cervical cancer. (1975) (24)
- Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study. (2017) (23)
- Antepartum pulmonary embolism. (1972) (22)
- Absorbable synthetic mesh (polyglactin 910) for the formation of a pelvic "lid" after radical pelvic resection. (1988) (22)
- Significant venous thromboembolism caused by pelvic lymphocysts: diagnosis and management. (1982) (22)
- Results of outpatient therapy of cervical intraepithelial neoplasia. (1981) (22)
- An experience with estrogen replacement therapy in breast cancer survivors. (1999) (21)
- Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva. (1978) (21)
- Diagnosis of Deep Venous Thrombosis in Obstetrics and Gynecology by Impedance Phlebography (1981) (20)
- Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial. (2015) (20)
- Management of early cervical neoplasia. (1975) (19)
- Hormone replacement therapy after cancers (2005) (19)
- Ovarian cancer screening. (1995) (19)
- Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected]. (2005) (19)
- Should symptomatic menopausal women be offered hormone therapy? (2006) (19)
- Second-look laparotomy in the patient with minimal residual stage III ovarian cancer (a Gynecologic Oncology Group Study). (1989) (18)
- Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study (2018) (18)
- The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group study. (2016) (17)
- Lymphovascular space invasion in uterine corpus cancer: What is its prognostic significance in the absence of lymph node metastases? (2015) (17)
- Recent advances in endometrial cancer. (1990) (17)
- A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix (1988) (17)
- A VP16-213- and cisplatin-containing regimen for treatment of refractory ovarian germ cell malignancies. (1984) (17)
- Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary A Gynecologic Oncology Group Study (1983) (16)
- Phase II trial of pyrazoloacridine in recurrent platinum-sensitive ovarian cancer: a Gynecologic Oncology Group study. (2002) (16)
- Chemoimmunotherapy in the management of primary stage III ovarian cancer: a Gynecologic Oncology Group study. (1979) (16)
- Preoperative evaluation of patients with recurrent carcinoma of the cervix. (1972) (16)
- Conseusus statements on prognostic factors in epithelial ovarian carcinoma. Report of the Consensus Meeting organized by the European Society of Gynaecological Oncology, ESGO. (2000) (15)
- Observations on the intraperitoneal distribution of chromic phosphate (32P) suspension for intraperitoneal therapy. (1983) (15)
- Chapter 1 – Preinvasive Disease of the Cervix (2007) (15)
- Intracavitary Corynebacterium parvum for treatment of malignant effusions. (1983) (15)
- Erratum: "American cancer society guidelines for the early detection of cancer: Update of early detection guidelines for prostate, colorectal, and endometrial cancer" (CA A Cancer Journal for Clinicians) (2001) vol. 51 (38-75)) (2001) (14)
- Absorbable synthetic mesh (910-polyglactin) intestinal sling to reduce radiation-induced small bowel injury in patients with pelvic malignancies. (1988) (14)
- Conservative management of cervical intraepithelial neoplasia. (1980) (14)
- Surgical training in gynecologic oncology: Past, present, future. (2020) (14)
- The abnormal pap smear—what to do next? (1981) (13)
- Uterine leiomyomas with retroperitoneal lymph node involvement. (1987) (13)
- Biology, diagnosis and management (1992) (13)
- Fertility after cryosurgery of the cervix. (1978) (13)
- Teaching gynecologic oncology in Low resource settings: a collaboration of health volunteers overseas and the society of gynecologic oncology. (2014) (12)
- Is positive pelvic lymphadenopathy a contraindication to radical surgery in recurrent cervical carcinoma (1974) (12)
- Superior vena cava syndrome associated with gynecologic malignancy. (1986) (12)
- Cryotherapy in the treatment of cervical intraepithelial neoplasia. (1983) (12)
- Should symptomatic menopausal women be offered hormone therapy? (2006) (11)
- Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study (2018) (11)
- Fine‐Needle Aspiration in Gynecology: Evaluation of Extrapelvic Lesions in Patients With Gynecologic Malignancy (1985) (11)
- Breast cancer: the role of hormone therapy. (2005) (11)
- Estrogen and progesterone receptor content of endometrial carcinomas: comparison of total tissue versus cancer component analysis. (1990) (11)
- Running mass closure of abdominal wounds using absorbable looped suture. (1991) (11)
- Adverse effect of electrosurgical loop excision on assignment of FIGO stage in cervical cancer: report of two cases. (1994) (11)
- Early Invasive Carcinoma of the Cervix (3− to 5-mm Invasion): Risk Factors and Prognosis (1998) (11)
- Treating Locally Advanced Cervical Cancer With Concurrent Chemoradiation Without Brachytherapy in Low-resource Countries (2016) (10)
- Methotrexate, hydroxyurea, and vincristine: Combination chemotherapy in squamous carcinoma of the female genitalia (1973) (10)
- Why do we continue to overtreat stage Ia carcinoma of the cervix? (2017) (10)
- Clinical Gynecologic Oncology (Online And Print) (2012) (10)
- Concurrent chemoradiation versus radiotherapy alone for the treatment of locally advanced cervical cancer in a low-resource setting (2016) (10)
- Stage IA cancer of the cervix: finally some resolution of definition and treatment? (1999) (10)
- The Undiagnosed Adnexal Mass After the Menopause (1986) (9)
- Final Overall Survival of the Phase III Randomised Trial of Chemotherapy with and without Bevacizumab for Advanced Cervical Cancer: An NRG Oncology/Gynecologic Oncology Group Study (2017) (9)
- Recurrence in endometrial carcinoma as a function of extended surgical staging data (1984) (9)
- Chapter 5 – Adenocarcinoma of the Uterus (2007) (9)
- Absorption of transfused chromium-labeled erythrocytes from the fetal peritoneal cavity in hydrops fetalis. (1966) (8)
- Tamoxifen responsiveness, hormone receptors, and tumor grade: A prospective study of 105 advanced ovarian cancer patients (1988) (8)
- Synuclein‐γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study (2017) (8)
- HRT and women who have had breast or endometrial cancer. (1999) (8)
- FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. (1999) (8)
- Controversies surrounding lymphadenectomy and postoperative radiotherapy in the treatment of carcinoma of the endometrium. (2008) (8)
- Management of endometrial adenocarcinoma stage I with surgical staging followed by tailored adjuvant radiation therapy. (1986) (7)
- FIGO staging of gynecologic cancer (1999) (7)
- The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma. (2008) (7)
- Microinvasive cancer vs occult cancer. (1979) (7)
- Ackerman's Surgical Pathology, Vols. I & II (6th Edition) (1981) (7)
- Induction of cytoplasmic progesterone receptor in human endometrial carcinoma transplanted into nude mice. (1984) (6)
- Management of premalignant cervical disease. (1971) (6)
- Combined adverse effect of African American race and deep stromal invasion on survival following radical hysterectomy for cervical cancer. (2008) (6)
- Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study. (2016) (6)
- A clinical evaluation of absorbable polydioxanone ligating clips in abdominal and pelvic operations. (1985) (6)
- Treatment of cervical dysplasia with electrocautery and tetracycline suppositories (1973) (6)
- A phase II study of PALA (NSC 224131) in patients with advanced ovarian carcinoma. A Gynecologic Oncology Group study. (1984) (5)
- Experience with a mass closure technique using continuous looped polyglyconate absorbable suture. (1994) (5)
- Indium-labelled platelet imaging of postoperative pelvic vein thrombi. (1983) (5)
- Percutaneous Nephrostomy in Gynecologic Oncology Patients (1989) (5)
- New gynecologic cancer staging. Author reply (1990) (5)
- Toxicity manifestations following intravenous Corynebacterium parvum administration to patients with ovarian and cervical carcinoma. (1978) (5)
- Carcinoma of the Cervix Associated with Pregnancy (1970) (4)
- Recommendations regarding estrogen replacement therapy after treatment of endometrial cancer. (1992) (4)
- Prognostic factors in relation to second-look laparotomy in ovarian cancer. (1989) (4)
- Effect of radiotherapeutic technique on local control in primary vaginal carcinoma (1993) (4)
- A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette‐Guerin in patients with suboptimal stage III and IV ovarian cancer: A gynecologic oncology group study (1991) (4)
- Cancer of the endometrium. (1980) (4)
- The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women. (2021) (4)
- Histologic control of biochemical steroid receptor analysis in endometrial carcinomas. (1985) (4)
- Vitamin-B12 deficiency following therapy in gynecologic oncology. (1984) (4)
- A case of parametrial lymph node involvement in stage IA2 squamous cell carcinoma of the cervix treated with radical hysterectomy and a review of the literature: a case report. (2012) (3)
- A preliminary analysis of prognostic factors in uterine sarcoma. A gynecologic oncology group study (1987) (3)
- How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery? (2009) (3)
- ALSO: Update 2001—Testing for Early Lung Cancer Detection Cancers: of Early Detection Guidelines for Prostate, Colorectal, and Endometrial American Cancer Society Guidelines for the Early Detection of Cancer: Update (2005) (3)
- 5 – Adenocarcinoma of the Uterine Corpus (2018) (3)
- Is positive pelvic lymphadenopathy a contraindication to radical surgery in recurrent cervical carcinoma? (1975) (3)
- Pyometra: A Complication of Cervical Cryosurgery (1972) (3)
- New gynecologic cancer staging. (1990) (3)
- Stage II carcinoma of the endometrium. (1979) (3)
- Extrafascial hysterectomy as adjuvant therapy after pelvic radiation and concurrent chemotherapy for locally advanced cervical carcinoma in low-resource settings (2012) (2)
- Use of estrogens after treatment for adenocarcinoma of the endometrium (1984) (2)
- Second-look laparotomy in ovarian cancer. (1994) (2)
- Preinvasive and Invasive Cervical Neoplasia in Pregnancy (1985) (2)
- Symposium on Cervical Neoplasia VI. Differing Views (1984) (2)
- Unusual metastasis in carcinoma of the cervix uteri. (1979) (2)
- Is Peritoneal Cytology a Prognostic Factor in Endometrial Cancer (2015) (2)
- What is the significance of gynecologic symptoms in the participants in the NSABP study? (2011) (2)
- Tumors, Including Endometriosis: Vincristine, Dactinomycin, and Cyclophosphamide in the Treatment of Malignant Germ Cell Tumors of the Ovary (1986) (2)
- Histologic composition of endometrial carcinomas analyzed for steroid receptor content. (1987) (2)
- Postoperative pelvic vein thrombosis and pulmonary embolism detected by indium 111-labeled platelet imaging: a case report. (1984) (2)
- Limited disease: role of surgery. (1994) (2)
- Comprar Clinical Gynecologic Oncology (Online And Print) | W. Creasman | 9780323074193 | Mosby (2012) (2)
- Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence. (2017) (2)
- Discussion: Current Issues in the Design of Ovarian Cancer Treatment Trials (2003) (2)
- Immunotherapy of ovarian cancer. (1983) (1)
- Report on Early Stage Invasive Vulvar Carcinoma (1997) (1)
- The role of racial genetic admixture with endometrial cancer outcomes: A Gynecologic Oncology Group study (2013) (1)
- Relationships of tubal ligation to endometrial carcinoma stage and mortality in the NRG oncology/gynecologic oncology group 210 trial (2015) (1)
- Intraperitoneal chromic phosphorous (P-32) as salvage therapy for persistent ovarian carcinoma (1987) (1)
- One score + 11 = 2000. (1989) (1)
- Clinical Synthesis Conference. Hormone replacement therapy (Reprinted from The Lancet, vol 354, pg 152-155, 1999) (2000) (1)
- Treatment of cervical dysplasia with electrocautery and tetracycline suppositories. (1974) (1)
- Adjuvant therapy in the treatment of stage II uterine carcinoma (2018) (1)
- Hormone replacement and breast cancer risk: reconsidering the data. (2009) (1)
- CANCER DETECTION : THE IMPORTANCE OF PAP SMEAR SCREENING (1999) (1)
- Follow-up of individualized therapy in patients with adenocarcinoma of the endometrium (1980) (0)
- Management of cervical cancer in low-resource settings (2012) (0)
- A perspective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group study (1990) (0)
- Management of Normal Pregnancy, Labor and Puerperium: FETAL COMPLICATIONS OF AMNIOCENTESIS (1968) (0)
- Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study (2016) (0)
- The Pap smear history of patients developing cervical cancer: An assessment of screening protocols (1986) (0)
- Conservative surgical management of superficially invasive state I vulvar carcinoma (1990) (0)
- Surgical Treatment of Endometrial Carcinoma (2009) (0)
- PREOPERATIVE EVALUATION OF PATIENTS WITH RECURRENT CARCINOMA OF THE CERVIX (1973) (0)
- Vulvar Dystrophies (1986) (0)
- How good (or bad) is the Pap smear? (1989) (0)
- Evaluation of Risk Factors for Infectious Morbidity in Postoperative Gynecologic Oncology Patients: A Time for a New Paradigm? (2013) (0)
- Prognostic Factors and Their Therapeutic Implications in Endometrial Carcinoma (1986) (0)
- Chapter 2 – Preinvasive Disease of the Vagina and Vulva and Related Disorders (2007) (0)
- Abstract of the Society of Gynecologic Oncologists Meeting January 11–13, 1981 Marcos Island, FloridaImmune complexes in ovarian cancer (1980) (0)
- A geospatial analysis of healthy food resource access to combat obesity in endometrial cancer survivors living in the deep south: Is it equitable? (2022) (0)
- Unreliability of urinary cytology in detecting gynecologic malignancy (1972) (0)
- Screening for cervical cancer: 1982--an update. (1982) (0)
- Endometrial adenocarcinoma estrogen receptor content: Associations of clinicopathologic features with immunohistochemical analysis compared with standard biochemical determination (1986) (0)
- Is laser surgery superior to cryosurgery for the treatment of high grade CIN? Con. (1991) (0)
- Running mass closure of abdominal wounds using an absorbable “looped” suture (1990) (0)
- Corrigendum to “Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-B” [Gynecol. Oncol. 98 (2005) 467–483] (2006) (0)
- Back and hip pain in pregnancy due to chordoma. (1967) (0)
- CON: Prophylactic Oophorectomy and Ovarian Cancer (1995) (0)
- Disparity of cervical cancer care delivery in low-middle income countries (2014) (0)
- Current therapy. Some current concepts in the management of ovarian carcinoma. (1977) (0)
- Immunohistologic localization of estrogen receptor using monoclonal (H222 γSp) antibody in endometrial carcinoma (1985) (0)
- Tumor proximity to serosal surface as an independent prognostic factor in FIGO stage 1 endometrial cancer (2021) (0)
- Should high-risk women take tamoxifen for breast cancer prevention? (2007) (0)
- 6 – Sarcoma of the Uterus (2018) (0)
- Cooperative clinical trials (1989) (0)
- Influence of Steroid Receptor Content on Prognosis of Early Stage Endometrial Carcinoma (1986) (0)
- Treatment outcomes for patients with locally advanced cervical cancer in a low-resource setting: Experience at a single institution in Tegucigalpa, Honduras (2015) (0)
- Ovarian metastases in stage IB cervical carcinoma (1990) (0)
- Abstract A85: Receipt of adjuvant endometrial carcinoma treatment according to race: An NRG Oncology/Gynecologic Oncology Group 210 Study (2018) (0)
- Genital Cytologic Abnormalities in Patients Having Therapeutic Abortion (1976) (0)
- Symposium on Cervical Neoplasia II. Cryosurgery1 (1984) (0)
- A phase II study of PAL A (NSC 224131) in patients with advanced ovarian carcinoma A Gynecologic Oncology Group study (1984) (0)
- Vaginal Hysterectomy for Treatment of Endometrial Cancer, 30 Years of Experience (2020) (0)
- Endometrial Adenocarcinoma Using a Monoclonal Antibody Immunohistochemical Analyses of Estrogen Receptor in Updated (2006) (0)
- Surgical staging in advanced cervical cancer (1989) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With William Thomas Creasman?
William Thomas Creasman is affiliated with the following schools:
